Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avidekel Oil for Agitation in Dementia
NCT03328676Phase 2Completed
- Start
- Dec 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Avidekel in agitation. Started Dec 2017; status: completed.
02
Drugs
Avidekel
03
Conditions
agitation
Beyond the preview
Go deeper on NCT03328676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03328676.